DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Clofazimine
Clofazimine
Successful Treatment of Rifampicin Resistant Case of Leprosy by WHO Recommended Ofloxacin and Minocycline Regimen
Clofazimine As a Treatment for Multidrug-Resistant Tuberculosis: a Review
Analysis of Mutations Leading to Para-Aminosalicylic Acid Resistance in Mycobacterium Tuberculosis
Trs
Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication?
PRODUCT MONOGRAPH Prmycobutin
MDR-TB): Evidence and Perspectives
Alphabetical Listing of ATC Drugs & Codes
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Clofazimine) Capsules, for Oral Use Bedaquiline May Cause Additive QT Prolongation
Tuberculosis Drug Information Guide, 2Nd Edition
Antimicrobial Resistance in Bacteria
And Second-Line Drugs in a Murine Model of Tuberculosis
Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment WHO Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
Lamprene (Clofazimine) in Leprosy
Top View
The Selection and Use of Essential Medicines
Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
CYCLOSERINE, PRETOMANID and SIRTURO®
Combinations Involving Dapsone, Rifampin, Clofazimine, and Ethionamide in the Treatment of M
Development of New Tuberculosis Drug Regimens
Estonian Statistics on Medicines 2017 1/42
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
The Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in Singapore: Are Patients from South-East Asia Eligible?
Failure with Acquired Resistance of an Optimised Bedaquiline-Based Treatment Regimen for Pulmonary Mycobacterium Avium Complex Disease
A Review on Agents for the Treatment of Leprosy Infection
Effectiveness and Safety of Clofazimine In€Multidrug-Resistant Tuberculosis
Antiinfectives Targeting Enzymes and the Proton Motive Force
WHO Treatment Guidelines for Drug- Resistant Tuberculosis
EML Application Form Commented-Explained.Docx
Evaluation of High-Dose Rifapentine Plus Clofazimine in the First-Line Regimen for Tuberculosis in the Mouse Model of Chemotherapy
Drug-Resistant Leprosy: Monitoring and Current Status
Discovery of a Highly Potent Novel Rifampicin Analog by Preparing A
Who-Pq Recommended Summary of Product Characteristics
Anti-Leprosy Drugs: Modes of Action and Mechanisms of Resistance in Mycobacterium Leprae
Clofazimine Shortens the Duration of the First-Line Treatment Regimen for Experimental Chemotherapy of Tuberculosis
A Mutation Associated with Clofazimine and Bedaquiline Cross-Resistance in MDR-TB Following Bedaquiline Treatment
Updates to the Tuberculosis (TB) Section of the Model List Of
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Treatment of Drug-Resistant Tuberculosis Barbara J Seaworth, MD November 22, 2019
Critically Important Antimicrobials for Human Medicine, 6Th Revision
Case Report: Rifampicin-Induced Thrombocytopenia in a Patient with Borderline Lepromatous Leprosy
Dapsone, Tablet
Treatment-Shortening Effect of a Novel Regimen Combining High-Dose Rifapentine And
Pharmaceuticals Appendix
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
ICD-10-CM Table of Drugs 2019
Clofazimine: Another Potential Magic Bullet for the Treatment of COVID-19?
Resolution Ap (2000) 1
ARPEC Protocol for Drug Utilization Study
P2119 Clofazimine Can Replace Ethambutol but Not Rifabutin In
Systematic Review of Clofazimine for the Treatment of Drug-Resistant Tuberculosis